You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Immunohistochemistry (IHC)

Showing 1 - 25 of 1,211
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Positron Emission Radiomics With PSMA Radioligands on Newly

Not yet recruiting
  • Prostate Cancer
  • Immunohistochemistry (IHC) analysis
  • (no location specified)
Apr 6, 2023

Breast Cancer Trial (Trastuzumab Deruxtecan)

Not yet recruiting
  • Breast Cancer
  • Trastuzumab Deruxtecan
  • (no location specified)
Jul 10, 2023

Survival Rate of HER2-Low Breast Cancer Patients

Completed
  • HER2 Low Breast Carcinoma
  • immunohistochemistry (IHC) and in situ hybridization (ISH) Test
  • (no location specified)
Mar 2, 2023

Lymphoma, Large B-Cell, Diffuse Trial in Worldwide (Venetoclax, Polatuzumab Vedotin, Rituximab)

Recruiting
  • Lymphoma, Large B-Cell, Diffuse
  • New York, New York
  • +19 more
Aug 17, 2022

Thyroid Carcinoma

Recruiting
  • Differentiated Thyroid Carcinoma
  • Medullary Thyroid Carcinoma
  • Immunohistochemistry (IHC)
  • +2 more
  • L'Hospitalet De Llobregat, Barcelona, Spain
  • +11 more
Mar 22, 2022

Lynch Syndrome Based on Next-generation Sequencing in Colorectal

Completed
  • Lynch Syndrome
  • next-generation sequencing
  • Fuzhou, Fujian, China
  • +6 more
Jul 14, 2021

Concordance of IHC4 Score Performed in Local or Central

Active, not recruiting
  • Breast Neoplasm Female
  • IHC4 score
  • Nice, France
    Centre Antoine Lacassagne
Feb 2, 2023

ATM Alterations by Next-Generation Sequencing and ATM

Completed
  • Solid Tumor, Unspecified, Adult
  • Determination of ATM alteration status.
  • Oklahoma City, Oklahoma
  • +2 more
Jul 29, 2022

Kidney Tumors Trial in Taoyuan (multiparametric and fat-detection magnetic resonance imaging (MRI))

Active, not recruiting
  • Kidney Neoplasms
  • multiparametric and fat-detection magnetic resonance imaging (MRI)
  • Taoyuan, Taiwan
    Li-Jen Wang
Nov 9, 2023

Breast Cancer, Hyperinsulinism, HER2-negative Breast Cancer Trial in New Haven (Dapagliflozin 10mg)

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Dapagliflozin 10mg
  • New Haven, Connecticut
    Yale Cancer Center Smilow Cancer Hospital
Aug 3, 2023

Advanced Solid Tumor Trial in Shanghai (B4T2-001 autologous CAR-T)

Recruiting
  • Advanced Solid Tumor
  • B4T2-001 autologous CAR-T
  • Shanghai, China/Shanghai, China
  • +1 more
Oct 3, 2023

Cancer Head Neck, Metastatic Cancer, Metastatic Lung Cancer Trial in New Haven (adnectin 18F-BMS-986192 Head and Neck Cancer,

Not yet recruiting
  • Cancer Head Neck
  • +2 more
  • adnectin 18F-BMS-986192 Head and Neck Cancer
  • adnectin 18F-BMS-986192 Brain Metastases
  • New Haven, Connecticut
    Yale University PET Center
Oct 10, 2022

HER2-Positive Cancer Trial in Wuhan

Active, not recruiting
  • HER2-Positive Cancer
    • Wuhan, Hubei, China
      TongjiHospital
    Sep 7, 2022

    Novel Hypoxia Imaging for Head and Neck Cancer: Imaging

    Not yet recruiting
    • Head and Neck Cancer
    • +3 more
    • [18F]MISO-PET/CT
    • (no location specified)
    Oct 29, 2023

    Breast Cancer, Breast Carcinoma, Metastatic Breast Cancer Trial in New York (18F-FDG PET/CT, [18F]-Fluoro-2-Deoxy-D-Glucose and

    Recruiting
    • Breast Cancer
    • +4 more
    • 18F-FDG PET/CT
    • +2 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Nov 17, 2023

    Duchenne Muscular Dystrophy Trial in United States (Ataluren)

    Completed
    Has Results
    • Duchenne Muscular Dystrophy
    • Phoenix, Arizona
    • +8 more
    Mar 10, 2022

    Glioblastoma, Recurrent Glioblastoma, Resectable Glioblastoma Trial in Los Angeles (Biospecimen Collection, Magnetic Resonance

    Recruiting
    • Glioblastoma
    • +2 more
    • Biospecimen Collection
    • +2 more
    • Los Angeles, California
      UCLA / Jonsson Comprehensive Cancer Center
    Oct 13, 2023

    Optimize Detection of NTRK1,2,3 Fusions in Thyroid Cancer

    Recruiting
    • Thyroid Cancer
    • NTRK fusion assessment
    • Roma, Italy
      Regina Elena National Cancer Institute
    Mar 31, 2023

    New Antigens Against Glioblastoma

    Not yet recruiting
    • Glioblastoma Multiforme
      • (no location specified)
      Jun 15, 2023

      Specific Protein Overexpression in Adult Non-Small Cell Lung

      Not yet recruiting
      • Non Small Cell Lung Cancer
        • (no location specified)
        Sep 29, 2023

        Cytomegalovirus Infections Trial in Lyon, Saint-Étienne (Biopsies, Blood samples)

        Recruiting
        • Cytomegalovirus Infections
        • Biopsies
        • Blood samples
        • Lyon, France
        • +1 more
        Apr 14, 2022

        Triple Negative Breast Cancer, Metastatic Breast Cancer, Mutation Trial in Shanghai (Everolimus, Investigator's Choice of

        Not yet recruiting
        • Triple Negative Breast Cancer
        • +2 more
        • Shanghai, Shanghai, China
          Fudan University Shanghai Cancer Center
        Jul 25, 2023

        Spread of Colorectal Carcinomatosis

        Completed
        • Peritoneal Carcinomatosis
        • Sampling peritoneal tissue
        • Ghent, Belgium
          Ghent University Hospital
        Dec 9, 2022

        Molecular Subtyping of Extensive Stage Small Cell Lung Cancer

        Recruiting
        • SCLC,Extensive Stage
        • PD-(L)1 antibody immunotherapy
        • Beijing, Beijing, China
          Peking University Cancer Hospital & Institute
        Jul 3, 2023

        Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial (Biopsy, Diagnostic Imaging, Novobiocin Sodium)

        Not yet recruiting
        • Metastatic Malignant Solid Neoplasm
        • Unresectable Malignant Solid Neoplasm
        • Biopsy
        • +2 more
        • (no location specified)
        Jan 14, 2023